Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
21,264.000000 Euro
Forbid offers above base price:
Request Reference:
06/03525.11/2023 - Aq. ADALImumab (Amgevita)
Request Name:
06/03525.11/2023 - Aquisição de ADALImumab 40 mg/0.8 ml Sol inj Caneta 0.8 ml SC (Amgevita) - (AQ_2022_55)
Phase:
Tendering Phase
State:
Awarded
Description:
06/03525.11/2023 - Aquisição de ADALImumab 40 mg/0.8 ml Sol inj Caneta 0.8 ml SC (Amgevita) - (AQ_2022_55)
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
A23141 - ADALIMUMAB [40 MG; SOL INJ; FRS/ SER/ CANETA]
21,264.000000 Euro
100
(
Days
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Rua Dr. Cândido Pinho 4520-211 União das freguesias de Santa Maria da Feira, Travanca, Sanfins e Espargo Santa Maria da Feira Aveiro PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
9/22/2023 9:54 AM
(UTC +1 hour)
National official publishing date and time (DR):
5/30/2022 12:00 PM
(UTC +1 hour)
Due datetime for receiving replies:
9/25/2023 5:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Advance Payments?
No
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
Anexo III.xlsx
Anexo III.xlsx
Download
Convite e CE_0603525.112023.pdf
Convite e CE_0603525.112023.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Questionário
1.1
Lote 1
Section for Lot - A23141 - ADALIMUMAB [40 MG; SOL INJ; FRS/ SER/ CANETA]
1.1.1
Lote 1
Bill of Quantities
*
(Os valores indicados não incluem o IVA)
Solicitou requisitos adicionais nesta lista de preços.
Preço Total
Total without VAT
0.000000
EUR
Cód. Artigo
Referência Interna
Descrição
Qt
Unidade
Preço Unitário
Preço Total
Reference
A23141
Internal Reference
Description
ADALIMUMAB [40 MG; SOL INJ; FRS/ SER/ CANETA]
Qty
578.000000
Unit
UN
Price per Unit
Total
Comentários do Comprador:
502248793 | Mylan, Lda. | CPA:2022055/120/0094 | NºAIM:5757000; 502942959 | Amgen Biofarmacêutica, Lda. | CPA:2022055/103/0176 | NºAIM:5732227; 504293753 | Fresenius Kabi Pharma Portugal, Lda. | CPA:2022055/51/0302 | NºAIM:5767041; 506415740 | Biogen Portugal - Sociedade Farmacêutica, Unipessoal, Lda. | CPA:2022055/320/0305 | NºAIM:5748652; 506415740 | Biogen Portugal - Sociedade Farmacêutica, Unipessoal, Lda. | CPA:2022055/320/0308 | NºAIM:5748660; 506985261 | Sandoz Farmacêutica, Lda. | CPA:2022055/326/0037 | NºAIM:5755566; 507002571 | Pharmakern Portugal, Produtos Farmacêuticos Soc. Unipessoal, Lda. | CPA:2022055/379/0061 | NºAIM:5813001; 507002571 | Pharmakern Portugal, Produtos Farmacêuticos Soc. Unipessoal, Lda. | CPA:2022055/379/0062 | NºAIM:5813019; 510229050 | AbbVie, Lda. | CPA:2022055/694/0172 | NºAIM:5671003;
Evaluation
Evaluation
Evaluation General Settings
Evaluation General Settings
Evaluation guideline
LowestPrice
Evaluation Method
Manual
Evaluation Items
Evaluation Items
Name
Lot
Regras de avaliação para o lote 1
1 - A23141 - ADALIMUMAB [40 MG; SOL INJ; FRS/ SER/ CANETA]
Critérios de Adjudicação
Peso (%)**
1
Preço
100
Define tie breaking rules?
Yes
No
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...